Back
Editas Medicine Vs. Regenxbio Industry Stock Comparison
Sell
22
EDIT
Editas Medicine
Last Price:
$1.33
Seasonality Move:
-11.28%
Sell
9
RGNX
Regenxbio
Last Price:
$7.65
Seasonality Move:
-8.12%
Sell
22
Editas Medicine (EDIT)
is a Sell
Is Editas Medicine a Buy, Sell or Hold?
-
The current Editas Medicine [EDIT] share price is $1.31. The Score for EDIT is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
-
EDIT is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
EDIT Stock Price Chart
What is Editas Medicine's stock price today?
-
The Editas Medicine share price today is $1.31Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EDIT is experiencing slight selling pressure.
EDIT Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.36 | Sell |
Relative Strength Index (14 RSI): | 23.89 | Sell |
Chaikin Money Flow: | -1676224 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (1.63 - 2.43) | Sell |
Bollinger Bands (100): | (2.37 - 4.05) | Sell |
RGNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 36.19 | Sell |
Chaikin Money Flow: | 5857711 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (8.41 - 9.97) | Sell |
Bollinger Bands (100): | (9.16 - 12.08) | Sell |
EDIT Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 1.54 | Sell |
20-day SMA: | 1.92 | Sell |
50-day SMA: | 2.6 | Sell |
200-day SMA: | 4.58 | Sell |
8-day EMA: | 1.53 | Sell |
20-day EMA: | 1.88 | Sell |
50-day EMA: | 2.47 | Sell |
200-day EMA: | 4.44 | Sell |
RGNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 8.27 | Sell |
20-day SMA: | 9.07 | Sell |
50-day SMA: | 9.56 | Sell |
200-day SMA: | 13.31 | Sell |
8-day EMA: | 8.2 | Sell |
20-day EMA: | 8.85 | Sell |
50-day EMA: | 9.58 | Sell |
200-day EMA: | 12.46 | Sell |
Editas Medicine Earnings Growth & EDIT Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.37 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.40 per share, and an increase next year of $1.18 per share.
Regenxbio Earnings Growth & RGNX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.72 per share, and an increase next year of $3.97 per share.
Editas Medicine Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Regenxbio Technical Analysis
Dec 9 | Dec 10 | Dec 11 | Dec 12 | Dec 13 | Dec 16 | Dec 17 | Dec 18 | Dec 19 | Dec 20 | |
---|---|---|---|---|---|---|---|---|---|---|
Dec | ||||||||||
09 | 10 | 11 | 12 | 13 | 16 | 17 | 18 | 19 | 20 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |